Supplementary Figure S11 from Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma
Authors:
- Smita MatkarSMSmita Matkar
- Michael P. EastMEMichael P. East
- Timothy J. StuhlmillerTSTimothy J. Stuhlmiller
- Gabriela M. WitekGWGabriela M. Witek
- Alvin FarrelAFAlvin Farrel
- Steven PastorSPSteven Pastor
- Denis O. OkumuDODenis O. Okumu
- Anne KennedyAKAnne Kennedy
- Joshua R. KalnaJKJoshua R. Kalna
- Esther R. BerkoEBEsther R. Berko
- Colleen E. CaseyCCColleen E. Casey
- Kateryna KrytskaKKKateryna Krytska
Open Access
- 2 September 2025
- other
- Published by American Association for Cancer Research (AACR)